Albert Boerla wins Genesis Prize 2022

Category : Awards Published on: January 22 2022

Share on facebook

The global pharmaceutical giant Pfizer Inc.’s Chairman and Chief Executive, Albert Bourla, has been awarded with the prestigious Genesis Prize 2022 on January 19, 2022.
He has been awarded for his efforts in leading the development of a COVID-19 vaccine (Pfizer–BioNTech COVID-19 vaccine).
The cash prize of this award is $1 million.
The annual prize is awarded to Jewish people who have achieved significant professional success, in recognition of their accomplishments, contributions to humanity, and commitment to Jewish values and/or to the State of Israel.
It is widely referred to as the “Jewish Nobel Prize”.

Telangana CM A. Revanth Reddy inaugurated the 23rd BioAsia summit focused on AI and automation in life sciences.
Read More....
NHAI launched ‘Bee Corridors’ to plant nectar-rich trees along highways, supporting pollinator conservation and ecosystem stability.
Read More....
Kerala approved India’s first graphene policy to establish the state as a global R&D hub for this advanced material.
Read More....
ZSI scientists discovered a new wingless soil-dwelling species, Lepidocampa sikkimensis, in the Eastern Himalayas.
Read More....
Assam approved a 3% job reservation for tea tribes and Adivasis in Class I and II state government positions.
Read More....
Delhi CM Rekha Gupta launched India’s first AI-enabled comprehensive education model at CM Shri School, Sarojini Nagar.
Read More....
Veteran actress Pravina Deshpande, known for her roles in films like Ready and Ek Villain, passed away at age 60.
Read More....
Jaisalmer will host the first Jain Chadar Mahotsav to worship 872-year-old sacred garments of Dada Shri Jindatt Suri Maharaj.
Read More....
Cricket star Smriti Mandhana won the BBC Indian Sportswoman of the Year 2025 for her role in India’s World Cup success.
Read More....
Union Health Minister J.P. Nadda launched SAHI and BODH initiatives to ensure ethical and safe AI adoption in Indian healthcare.
Read More....